{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:46:49Z","timestamp":1783594009013,"version":"3.55.0"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"unspecified","delay-in-days":266,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>With the aim to elucidate gonococcal antimicrobial resistance (AMR)\u2013risk factors, we undertook a retrospective analysis of the molecular epidemiology and AMR of 104<jats:italic>Neisseria gonorrhoeae<\/jats:italic>isolates from clinical samples (urethra, rectum, pharynx and cervix) of 94 individuals attending a sexually transmitted infection clinic in Madrid (Spain) from July to October 2016, and explored potential links with socio-demographic, behavioural and clinical factors of patients. Antimicrobial susceptibility was determined by<jats:italic>E<\/jats:italic>-tests, and isolates were characterised by<jats:italic>N. gonorrhoeae<\/jats:italic>multi-antigen sequence typing. Penicillin resistance was recorded for 15.4% of isolates, and most were susceptible to tetracycline, cefixime and azithromycin; a high incidence of ciprofloxacin resistance (~40%) was found. Isolates were grouped into 51 different sequence types (STs) and 10 genogroups (G), with G2400, ST5441, ST2318, ST12547 and G2992 being the most prevalent. A significant association (<jats:italic>P<\/jats:italic>= 0.015) was evident between HIV-positive MSM individuals and having a ciprofloxacin-resistant strain. Likewise, a strong association (<jats:italic>P<\/jats:italic>= 0.047) was found between patient age of MSM and carriage of isolates expressing decreased susceptibility to azithromycin. A decrease in the incidence of AMR gonococcal strains and a change in the strain populations previously reported from other parts of Spain were observed. Of note, the prevalent multi-drug resistant genogroup G1407 was represented by only three strains in our study, while the pan-susceptible clones such as ST5441, and ST2318, associated with extragenital body sites were the most prevalent.<\/jats:p>","DOI":"10.1017\/s095026881900150x","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T07:31:42Z","timestamp":1569310302000},"source":"Crossref","is-referenced-by-count":8,"title":["Epidemiology, molecular characterisation and antimicrobial susceptibility of<i>Neisseria gonorrhoeae<\/i>isolates in Madrid, Spain, in 2016"],"prefix":"10.1017","volume":"147","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9056-7489","authenticated-orcid":false,"given":"M. D.","family":"Guerrero-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. B.","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"Guerras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Tello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Clavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ayerdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Carrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Mozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Del Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8339-0950","authenticated-orcid":false,"given":"R.","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"S095026881900150X_ref39","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051020"},{"key":"S095026881900150X_ref36","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00010-14"},{"key":"S095026881900150X_ref34","unstructured":"Public Health England (2016) Surveillance of antimicrobial resistance in Neisseria gonorrhoeae. Available at https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/771134\/GRASP_Report_2016.pdf (Accessed 1 February 2019)."},{"key":"S095026881900150X_ref32","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2012-050604"},{"key":"S095026881900150X_ref31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu521"},{"key":"S095026881900150X_ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1683-8"},{"key":"S095026881900150X_ref29","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181bf575c"},{"key":"S095026881900150X_ref28","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ785"},{"key":"S095026881900150X_ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2696-7"},{"key":"S095026881900150X_ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2015.01.017"},{"key":"S095026881900150X_ref27","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000489"},{"key":"S095026881900150X_ref23","first-page":"194","article-title":"Risk factors for antimicrobial-resistant Neisseria gonorrhoeae and characteristics of patients infected with gonorrhea","volume":"36","author":"Fuertes","year":"2018","journal-title":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"},{"key":"S095026881900150X_ref10","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323"},{"key":"S095026881900150X_ref14","volume-title":"Global Action Plan on Antimicrobial Resistance","year":"2015"},{"key":"S095026881900150X_ref8","volume-title":"Gonococcal Antimicrobial Susceptibility Surveillance in Europe, 2015","year":"2017"},{"key":"S095026881900150X_ref35","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.36.30335"},{"key":"S095026881900150X_ref7","unstructured":"World Health Organization (2016) WHO guidelines for the treatment of Neisseria gonorrhoeae. World Health Organization. Available at http:\/\/www.who.int\/iris\/handle\/10665\/246114 (Accessed 11 January 2019)."},{"key":"S095026881900150X_ref12","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.47.1800617"},{"key":"S095026881900150X_ref5","doi-asserted-by":"publisher","DOI":"10.1177\/0956462412472837"},{"key":"S095026881900150X_ref26","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000403"},{"key":"S095026881900150X_ref18","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2016"},{"key":"S095026881900150X_ref37","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000185"},{"key":"S095026881900150X_ref22","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881600234X"},{"key":"S095026881900150X_ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1512757"},{"key":"S095026881900150X_ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.18.03.20358-en","article-title":"Molecular epidemiological typing within the European gonococcal antimicrobial resistance surveillance programme reveals predominance of a multidrug resistant clone","volume":"18","author":"Chisholm","year":"2013","journal-title":"Eurosurveillance"},{"key":"S095026881900150X_ref38","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2009.037135"},{"key":"S095026881900150X_ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143304"},{"key":"S095026881900150X_ref13","volume-title":"Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae","year":"2012"},{"key":"S095026881900150X_ref2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-11"},{"key":"S095026881900150X_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2011.11.010"},{"key":"S095026881900150X_ref3","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05760-11"},{"key":"S095026881900150X_ref17","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2016) Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0."},{"key":"S095026881900150X_ref6","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"Morbidity and Mortality Weekly Report Recommendations and Reports"},{"key":"S095026881900150X_ref11","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2019.24.10.1900147"},{"key":"S095026881900150X_ref15","volume-title":"Response Plan to Control and Manage the Threat of Multidrug-Resistant Gonorrhoea in Europe, 2012"},{"key":"S095026881900150X_ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2707-z"},{"key":"S095026881900150X_ref33","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1128\/JCM.35.11.2985-2988.1997","article-title":"Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: Comparison of methods","volume":"35","author":"Daly","year":"1997","journal-title":"Journal of Clinical Microbiology"},{"key":"S095026881900150X_ref19","doi-asserted-by":"publisher","DOI":"10.1086\/383047"},{"key":"S095026881900150X_ref21","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msw054"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S095026881900150X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T12:03:50Z","timestamp":1664453030000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S095026881900150X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":39,"alternative-id":["S095026881900150X"],"URL":"https:\/\/doi.org\/10.1017\/s095026881900150x","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"article-number":"e274"}}